Screening for Lipid Disorders in Children and Adolescents

Brandy Peaker, MD, MPH

Patrick Dideum, MD

Irina Arkhipova-Jenkins, MD

Evan Finlay, DO

American Family Physician. 2024;110(3):295-296.

Author disclosure: No relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

BRANDY PEAKER, MD, MPH, is a medical officer with the U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality.

PATRICK DIDEUM, MD, is a general preventive medicine resident at Johns Hopkins University, Bloomberg School of Public Health.

IRINA ARKHIPOVA-JENKINS, MD, is a preventive medicine resident with Stony Brook Medicine, Department of Family, Population, and Preventive Medicine.

EVAN FINLAY, DO, is a preventive medicine resident at the Uniformed Services University of the Health Sciences.

Author disclosure: No relevant financial relationships.

1.Barry MJ, Nicholson WK, Silverstein M, et al. Screening for lipid disorders in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA. 2023;330(3):253-260.
2.Grossman DC, Bibbins-Domingo K, Curry SJ, et al. Screening for obesity in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA. 2017;317(23):2417-2426.
3.Barlow SE; Expert Committee. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007;120(suppl 4):S164-S192.
4.National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128(suppl 5):S213-S256.
5.Guirguis-Blake JM, Evans CV, Coppola EL, et al. Screening for lipid disorders in children and adolescents: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2023;330(3):261-274.